UBS Group
SHC icon

UBS Group’s Sotera Health SHC Stock Holding History

UBS Group’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.16M Sell
359,831
-81,680
-19% -$1.36M ﹤0.01% 4055
2025
Q4 		$7.79M Sell
441,511
-67,754
-13% -$1.12M ﹤0.01% 3556
2025
Q3 		$8.01M Sell
509,265
-905,402
-64% -$12.7M ﹤0.01% 3537
2025
Q2 		$15.7M Buy
1,414,667
+54,795
+4% +$642K ﹤0.01% 2628
2025
Q1 		$15.9M Sell
1,359,872
-107,001
-7% -$1.38M ﹤0.01% 2578
2024
Q4 		$20.1M Buy
1,466,873
+1,232,373
+526% +$17.9M ﹤0.01% 2315
2024
Q3 		$3.92M Buy
234,500
+111,283
+90% +$1.63M ﹤0.01% 3329
2024
Q2 		$1.46M Buy
123,217
+6,312
+5% +$72.1K ﹤0.01% 4064
2024
Q1 		$1.4M Buy
116,905
+116,545
+32,374% +$1.73M ﹤0.01% 4297
2023
Q4 		$6.07K Sell
360
-3,432
-91% -$48.6K ﹤0.01% 7730
2023
Q3 		$56.8K Sell
3,792
-129
-3% -$2.18K ﹤0.01% 6216
2023
Q2 		$73.9K Sell
3,921
-90,810
-96% -$1.44M ﹤0.01% 6228
2023
Q1 		$1.7M Buy
94,731
+13,057
+16% +$218K ﹤0.01% 3598
2022
Q4 		$680K Buy
81,674
+81,325
+23,302% +$607K ﹤0.01% 4425
2022
Q3 		$2K Sell
349
-63,431
-99% -$1.05M ﹤0.01% 9772
2022
Q2 		$1.25M Sell
63,780
-30,301
-32% -$635K ﹤0.01% 3540
2022
Q1 		$2.04M Buy
94,081
+74,941
+392% +$1.59M ﹤0.01% 3398
2021
Q4 		$451K Sell
19,140
-119
-0.6% -$2.85K ﹤0.01% 5061
2021
Q3 		$504K Buy
19,259
+15,830
+462% +$383K ﹤0.01% 4730
2021
Q2 		$83K Sell
3,429
-7,366
-68% -$181K ﹤0.01% 6025
2021
Q1 		$269K Buy
10,795
+8,882
+464% +$235K ﹤0.01% 5276
2020
Q4 		$52K Buy
+1,913
New +$51.4K ﹤0.01% 6151

Other funds holding SHC

DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

UBS Group's SHC Position: Q1 2026 in Review

UBS Group reduced its Sotera Health (SHC) stake by 19% in Q1 2026, selling an estimated $1.36M and leaving 359,831 shares worth $5.16M. The position accounts for ﹤0.01% of the portfolio, ranked #4055.

UBS Group first reported a position in SHC in Q4 2020 and has held it in 22 quarters since. The position peaked at $20.1M in Q4 2024. 296 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • UBS Group held 359,831 shares of Sotera Health worth $5.16M as of Q1 2026.
  • UBS Group sold 81,680 Sotera Health shares in Q1 2026, an estimated $1.36M.
  • Sotera Health made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4055 holding.
  • UBS Group first reported a position in Sotera Health in Q4 2020 and has held it in 22 quarters since.
  • UBS Group's Sotera Health position peaked at $20.1M in Q4 2024.
  • 296 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.